Latest Bioethics Stories
Company continues to expand its board and leadership team as it moves toward completion of its Phase 3 gene therapy program and advancement of the industry's deepest pipeline of gene-based medicines PHILADELPHIA,
DUBLIN, February 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/wlcf6t/mice_model_market) has announced the addition of the
Presentation to be Webcast Live on February 10, 2014 at 3 PM EST PRINCETON, N.J., Feb. 5, 2014 /PRNewswire/ -- Soligenix, Inc.
COLOGNE, Germany, February 3, 2014 /PRNewswire/ -- Highly-effective unknown doping agents have emerged; cannot be tested A few days before the opening of
Study Does Not Meet Primary Endpoint SOUTH SAN FRANCISCO, Calif., Jan. 29, 2014 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc.
UEP / HSUS Proposal Would Preempt State Laws and Keep Hens in Cages SAN FRANCISCO, Jan.
Natreon, Inc, and NutraGenesis, LLC are pleased to announce a new study published on Sensoril® demonstrates Sensoril’s ability to significantly improve cognitive and psychomotor performance.
LONDON, January 23, 2014 /PRNewswire/ -- The recent BBC report on January 3rd revealed shocking figures of obesity quadrupling to nearly one billion in the developing world
Xtalks presents an exciting live webinar on Thursday, February 13, 2014 at 11:00am EST (16:00 GMT).
The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...
- In medieval musical notation, a sign or neume denoting a shake or trill.
More Images (1 images) »